EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,713,000 | +1.2% | 270,751 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $2,680,000 | +0.4% | 270,751 | 0.0% | 0.03% | -18.4% |
| Q1 2022 | $2,670,000 | +384.6% | 270,751 | +379.6% | 0.04% | +375.0% |
| Q4 2021 | $551,000 | +109.5% | 56,451 | +110.1% | 0.01% | +33.3% |
| Q3 2021 | $263,000 | – | 26,874 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |